These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31990955)

  • 41. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
    Guo Y; Yue P; Wang Y; Chen G; Li Y
    Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An integrative approach identified genes associated with drug response in gastric cancer.
    Zhou J; Yong WP; Yap CS; Vijayaraghavan A; Sinha RA; Singh BK; Xiu S; Manesh S; Ngo A; Lim A; Ang C; Xie C; Wong FY; Lin SJ; Wan WK; Tan IB; Flotow H; Tan P; Lim KH; Yen PM; Goh LK
    Carcinogenesis; 2015 Apr; 36(4):441-51. PubMed ID: 25742747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer.
    Yu C; Xue P; Zhang L; Pan R; Cai Z; He Z; Sun J; Zheng M
    World J Surg Oncol; 2018 Aug; 16(1):174. PubMed ID: 30134903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PEA‑15 contributes to the clinicopathology and AKT‑regulated cisplatin resistance in gastric cancer.
    Jiang X; Zhang C; Li W; Jiang D; Wei Z; Lv M; Xie X; Sun X
    Oncol Rep; 2019 Mar; 41(3):1949-1959. PubMed ID: 30569123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
    Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
    Ni F; Yan CY; Zhou S; Hui PY; Du YH; Zheng L; Yu J; Hu XJ; Zhang ZG
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):593-605. PubMed ID: 30032449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment.
    Ikeguchi M; Liu J; Kaibara N
    Apoptosis; 2002 Feb; 7(1):23-9. PubMed ID: 11773702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
    Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
    Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alteration of gene expression and DNA methylation in drug-resistant gastric cancer.
    Maeda O; Ando T; Ohmiya N; Ishiguro K; Watanabe O; Miyahara R; Hibi Y; Nagai T; Yamada K; Goto H
    Oncol Rep; 2014 Apr; 31(4):1883-90. PubMed ID: 24504010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Global gene expression analysis of knockdown Triosephosphate isomerase (TPI) gene in human gastric cancer cell line MGC-803.
    Ouyang P; Lin B; Du J; Pan H; Yu H; He R; Huang Z
    Gene; 2018 Mar; 647():61-72. PubMed ID: 29307852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ginkgo biloba extract enhances chemotherapy sensitivity and reverses chemoresistance through suppression of the KSR1-mediated ERK1/2 pathway in gastric cancer cells.
    Liu SQ; Xu CY; Qin MB; Tan L; Zhuge CF; Mao YB; Lai MY; Huang JA
    Oncol Rep; 2015 Jun; 33(6):2871-82. PubMed ID: 25962735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer.
    Wu DM; Hong XW; Wang LL; Cui XF; Lu J; Chen GQ; Zheng YL
    Int J Biochem Cell Biol; 2018 Sep; 102():59-70. PubMed ID: 29953965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancer.
    Yu HE; Wang F; Yu F; Zeng ZL; Wang Y; Lu YX; Jin Y; Wang DS; Qiu MZ; Pu HY; Kang TB; Xie D; Ju HQ; Xu RH; Luo HY
    Cell Death Dis; 2019 May; 10(6):413. PubMed ID: 31138787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Knockdown of PLA2G2A sensitizes gastric cancer cells to 5-FU in vitro.
    Chen D; Jiao XL; Liu ZK; Zhang MS; Niu M
    Eur Rev Med Pharmacol Sci; 2013 Jul; 17(13):1703-8. PubMed ID: 23852891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
    Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X
    J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
    Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
    Bai T; Tanaka T; Yukawa K; Umesaki N
    Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tetraspanin family identified as the central genes detected in gastric cancer using bioinformatics analysis.
    Qi W; Sun L; Liu N; Zhao S; Lv J; Qiu W
    Mol Med Rep; 2018 Oct; 18(4):3599-3610. PubMed ID: 30106120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.